BKN301 is a series a startup based in Indonesia. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
BKN301 is a clinical-stage biotech company focused on the discovery and development of innovative therapies targeting gastrointestinal (GI) diseases with high unmet medical need.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky